Core Insights - The animal health sector experienced a slight increase of 0.14% on November 12, with *ST Lvkang leading the gains [1] - The Shanghai Composite Index closed at 4000.14, down 0.07%, while the Shenzhen Component Index closed at 13240.62, down 0.36% [1] Stock Performance Summary - *ST Lvkang (002868) closed at 36.77, up 5.00% with a trading volume of 62,400 shares and a transaction value of 226 million [1] - Other notable performers included: - Qudongli (920275) at 10.76, up 3.86% [1] - Yongshun Biological (920729) at 10.15, up 1.81% [1] - Biological Shares (600201) at 10.76, up 1.22% [1] - Zhongmu Shares (600195) at 7.98, up 0.50% [1] Capital Flow Analysis - The animal health sector saw a net outflow of 35.94 million from institutional investors, while retail investors contributed a net inflow of 20.57 million [2] - The capital flow for individual stocks showed: - KQ Bio (688526) had a net inflow of 7.99 million from institutional investors [3] - Biological Shares (600201) had a net inflow of 6.25 million from institutional investors [3] - However, KQ Bio (688526) also experienced a net outflow of 16.05 million from retail investors [3]

Core Insights - The animal health sector experienced a 1.04% increase on November 11, with *ST Lvkang leading the gains [1] - The Shanghai Composite Index closed at 4002.76, down 0.39%, while the Shenzhen Component Index closed at 13289.0, down 1.03% [1] Stock Performance - *ST Lvkang (002868) closed at 35.02, up 5.01% with a trading volume of 1196 lots and a transaction value of 4.1884 million yuan [1] - Other notable performers included: - Qudongli (920275) at 10.36, up 4.65% [1] - Yongshun Biological (920729) at 9.97, up 2.15% [1] - Biological Shares (600201) at 10.63, up 1.24% [1] - Plai Ke (603566) at 14.42, up 1.19% [1] Capital Flow - The animal health sector saw a net outflow of 2.5437 million yuan from institutional investors and 7.7575 million yuan from speculative funds, while retail investors had a net inflow of 10.3012 million yuan [1] - Specific stock capital flows included: - Biological Shares (600201) with a net inflow of over 9.2092 million yuan from institutional investors [2] - *ST Lvkang (002868) had a net inflow of 1.1031 million yuan from retail investors [2] - Huayi Biological (603718) experienced a net outflow of 4.1338 million yuan from institutional investors [2]

Core Insights - The animal health sector experienced a slight increase of 0.55% on November 7, with *ST Lvkang leading the gains [1] - The Shanghai Composite Index closed at 3997.56, down 0.25%, while the Shenzhen Component Index closed at 13404.06, down 0.36% [1] Stock Performance - *ST Lvkang (002868) closed at 31.76, up 4.99% with a trading volume of 12,000 hands and a transaction value of 37.6483 million yuan [1] - Other notable stocks included: - Biological Shares (600201) at 10.52, up 1.64% with a trading volume of 234,300 hands [1] - Driving Force (920275) at 9.88, up 1.13% with a trading volume of 7,484 hands [1] - Zhongmu Shares (600195) at 7.75, up 0.65% with a trading volume of 77,200 hands [1] Capital Flow - The animal health sector saw a net outflow of 5.144 million yuan from institutional investors, while retail investors experienced a net outflow of 11.0652 million yuan [2] - Conversely, speculative funds recorded a net inflow of 16.2092 million yuan [2] Detailed Capital Flow Analysis - Major stocks and their capital flow included: - Biological Shares (600201) with a net inflow of 20.3753 million yuan from institutional investors [3] - *ST Lvkang (002868) had a net inflow of 2.9042 million yuan from institutional investors [3] - Huisheng Biological (300871) faced a significant net outflow of 18.6925 million yuan from institutional investors [3]

Core Insights - The animal health sector experienced a slight increase of 0.36% on November 6, with *ST Lvkang leading the gains [1] - The Shanghai Composite Index closed at 4007.76, up 0.97%, while the Shenzhen Component Index closed at 13452.42, up 1.73% [1] Stock Performance - *ST Lvkang (002868) closed at 30.25, with a rise of 5.00% and a trading volume of 32,200 hands, amounting to a transaction value of 96.94 million yuan [1] - Other notable stocks include: - KQ Bio (688526) at 16.07, up 0.69% [1] - Biological Shares (600201) at 10.35, up 0.68% with a transaction value of 153 million yuan [1] - Ruipu Biological (300119) at 20.46, up 0.20% [1] - Pulaike (603566) at 14.09, up 0.14% [1] Capital Flow - The animal health sector saw a net outflow of 17.47 million yuan from institutional investors, while retail investors contributed a net inflow of 8.89 million yuan [2] - The capital flow for individual stocks indicates: - *ST Lvkang had a net inflow of 7.56 million yuan from institutional investors [3] - KQ Bio experienced a net inflow of 4.84 million yuan [3] - Biological Shares had a net inflow of 2.64 million yuan [3]

上海海利生物技术股份有限公司 2025 年第二次临时股东会 会议资料 二〇二五年十一月 上海 上海海利生物技术股份有限公司 2025 年第二次临时股东会议程 一、现场会议召开时间 2025 年 11 月 14 日（星期五）13:30 二、网络投票时间 1、互联网投票平台投票时间：2025 年 11 月 14 日的 9:15－15:00 2、交易系统投票平台投票时间：2025 年 11 月 14 日的交易时间段，即 9:15 －9:25，9:30－11:30，13:00－15:00 三、现场会议召开地点 上海市黄浦区淮海中路 138 号 805 室 （三）推举两名监票人、一名计票人，并宣读议案审议和表决办法 （四）宣读和审议会议议案 1、关于聘任公司 2025 年度会计师事务所的议案 上述议案采用非累积投票方式表决。 四、会议主持 董事长张海明先生 五、会议议程 （一）主持人宣布 2025 年第二次临时股东会开始，报告出席会议的股东人 数及代表股份总数 （二）介绍出席会议的董事、高级管理人员、见证律师等人员情况 （五）股东发言、提问及公司回答 （六）现场会议投票表决 1、股东填写表决票 2、计票人、监票人计票 ...

Group 1 - The agricultural, animal husbandry, and fishery sector showed strong performance, with the only agricultural ETF (159275) rising by 1.21% at the close [1][2] - Key stocks in the sector included edible fungi, pig farming, and seeds, with notable gains from companies like Zhongxing Junye and Luoniushan, both hitting the daily limit [1][3] - The recent rebound in pig prices, with an increase of 6.1% from the previous week, has positively impacted the sector [2][3] Group 2 - Short-term pressure on pig sales has eased, with a decrease in the overall output from large enterprises and an increase in secondary fattening [3][4] - The industry is expected to focus on quality improvement and efficiency, with a gradual elimination of outdated production capacity [4][5] - The agricultural ETF (159275) is currently at a relatively low price-to-book ratio of 2.56, indicating a good long-term investment opportunity [3][5] Group 3 - The agricultural ETF tracks the CSI Agricultural, Animal Husbandry, and Fishery Index, with a significant concentration in leading companies in the sector, including Muyuan Foods and Wens Foodstuffs [5][6] - Investors can also access the agricultural ETF through linked funds for broader exposure to the sector [5]

Core Insights - The animal health sector experienced a decline of 0.35% on November 3, with Reap Bio leading the losses [1] - The Shanghai Composite Index closed at 3976.52, up 0.55%, while the Shenzhen Component Index closed at 13404.06, up 0.19% [1] Stock Performance Summary - Hai Li Biological (603718) closed at 7.02, up 2.03% with a trading volume of 101,600 shares and a turnover of 70.93 million yuan [1] - Shen Lian Biological (688098) closed at 11.36, up 1.43% with a trading volume of 133,100 shares and a turnover of 150 million yuan [1] - Yong Shun Biological (920729) closed at 10.09, up 1.00% with a trading volume of 23,800 shares and a turnover of 24.09 million yuan [1] - The worst performer was Reap Bio (300119), which closed at 21.01, down 2.51% with a trading volume of 103,300 shares and a turnover of 219 million yuan [2] Capital Flow Analysis - The animal health sector saw a net outflow of 35.26 million yuan from institutional investors, while retail investors had a net inflow of 26.79 million yuan [2] - The main capital inflow was observed in Shen Lian Biological, with a net inflow of 4.03 million yuan from institutional investors [3] - Conversely, Reap Bio experienced a net outflow of 1.29 million yuan from institutional investors [3]

Market Overview - The animal health sector experienced a decline of 2.79% on October 30, with Jinhe Biology leading the drop [1] - The Shanghai Composite Index closed at 3986.9, down 0.73%, while the Shenzhen Component Index closed at 13532.13, down 1.16% [1] Individual Stock Performance - Jinhe Biology (002688) closed at 6.25, down 7.13% with a trading volume of 578,000 shares and a transaction value of 367 million yuan [1] - Keqian Biology (688526) closed at 16.15, down 6.76% with a trading volume of 139,800 shares and a transaction value of 228 million yuan [1] - Maofeng Holdings (002141) closed at 3.92, down 5.08% with a trading volume of 461,300 shares and a transaction value of 18.3 million yuan [1] - Other notable declines include Dayu Biology (920970) down 2.69%, and Pulaike (603566) down 2.68% [1] Capital Flow Analysis - The animal health sector saw a net outflow of 84.7 million yuan from institutional investors, while retail investors experienced a net outflow of 16.5 million yuan [1] - Speculative funds recorded a net inflow of 101 million yuan [1] Detailed Capital Flow for Selected Stocks - Keqian Biology (688526) had a net inflow of 39.6 million yuan from institutional investors, while retail investors saw a net outflow of 60.9 million yuan [2] - Huisheng Biology (300871) experienced a net inflow of 18.3 million yuan from institutional investors, with a net outflow of 21.2 million yuan from retail investors [2] - Other stocks like Pulaike (603566) and Maofeng Holdings (002141) also reported significant net outflows from institutional investors [2]

Core Viewpoint - The company has announced significant changes regarding its stock incentive plan, including the repurchase and cancellation of certain restricted stocks and stock options due to unmet performance conditions and employee departures [52][64][66]. Financial Data - The company reported a cash dividend of 0.0784 yuan per share, totaling approximately 51.4 million yuan distributed to shareholders [5]. - The total number of shares will decrease from 655,662,200 to 651,904,700 after the repurchase of 3,757,500 restricted stocks [50][66]. Board Meeting and Resolutions - The fifth board meeting was held on October 28, 2025, where several key resolutions were passed, including the approval of the third-quarter report and the adjustment of the stock incentive plan [10][12][58]. - The board approved the appointment of Sigma Accounting Firm for the 2025 financial audit [12]. Stock Incentive Plan Adjustments - The company will repurchase 243,750 restricted stocks due to unmet conditions for the second release period of the stock incentive plan [64][66]. - The repurchase price for restricted stocks has been adjusted to 4.6729 yuan per share, and the exercise price for stock options has been adjusted to 9.4429 yuan per option [61][63]. Upcoming Events - The company will hold a second extraordinary general meeting on November 14, 2025, to discuss the resolutions passed by the board [20][32]. - An investor performance briefing is scheduled for November 21, 2025, to discuss the third-quarter results and address investor inquiries [24][25].

Core Insights - The company reported a revenue of 149,742,032.70 yuan for the first three quarters of 2025, representing a year-on-year decline of 14.15% [2] - The net profit attributable to shareholders of the listed company was 20,329,681.80 yuan, showing a slight year-on-year increase of 0.77% [2] Financial Performance - Revenue for the first three quarters of 2025: 149.74 million yuan, down 14.15% year-on-year [2] - Net profit for the same period: 20.33 million yuan, up 0.77% year-on-year [2]